Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

A recent clinical trial published in JAMA Psychiatry reveals disappointing results in testing the effectiveness of at-home transcranial direct current stimulation (tDCS). Researchers sought to explore ...

A noninvasive brain stimulation treatment improved depression and anxiety symptoms among older adults in a new University of Florida-led study. Improvements in depression and anxiety symptoms were ...

Transcranial direct current stimulation (tDCS) provides no additional benefit when added to selective serotonin reuptake inhibitor (SSRI) therapy for adults with major depressive disorder (MDD), ...

Researchers who conducted a small randomized trial of a form of non-invasive brain stimulation called tDCS (transcranial direct current stimulation) have found mechanistic evidence supporting its ...

NEW YORK--(BUSINESS WIRE)--Soterix Medical, Inc. announced today that it is seeking physicians and clinical centers across the European Union (EU) to join its tDCS-LTE™ Depression Treatment ...

NEW YORK--(BUSINESS WIRE)--Soterix Medical Inc (SMI) is pleased to report positive results from two double-blind, sham-controlled clinical trials of its proprietary transcranial Direct Current ...

Program will integrate existing neurocare clinics with HOPE Therapeutics clinics and will engage the already-installed base ...

Radial reports that teen depression is prevalent yet under-treated. Effective options include therapy, antidepressants, and ...